Comparative analysis of plasma leptin levels in both genders of patients with essential hypertension and healthy subjects

dc.contributor.authorCanatan, H
dc.contributor.authorBakan, I
dc.contributor.authorAkbulut, M
dc.contributor.authorBaydas, G
dc.contributor.authorHalifeoglu, I
dc.contributor.authorGursu, MF
dc.date.accessioned2026-08-12T17:02:16Z
dc.date.issued2004
dc.departmentFırat Üniversitesi
dc.description.abstractWhile pathogenesis of hypertension is not clearly deciphered yet, increase in body, weight, most of the time, is associated, with hypertension. There are, reports indicating that leptin, product. of the Ob gene mainly synhesized in adipocytes, may have role(s) in hypertension, but contribution of the gender is rather contradictive. In the present study, plasma leptin levels in patients of both genders With hypertension and normotensive controls were measured and the relationship between plasma leptin levels and BMI were evaluated in both sexes. Total of 62 patients (31 M/31 F) diagnosed with essential hypertension who were not under any antihypertensive medication were admitted into the study. The control group wag composed of 56 (25 M/31 F) age-, BMI- and sex matched healthy normotensive volunteers. Plasma leptin levels were determined by a commercial ELISA kit. Plasma leptin and leptin/BMI levels (Mean+/-SEM) of women (n:62) were., significantly higher than men (n:56) (20.10+/-1.47 ng/ml versus 4.72+/-0.50 ng/ml; p<0.0001). Plasma leptin and leptin/BMI levels of patients of both genders with hypertension were significantly higher than in normotensive subjects (p<0.05). Leptin and leptin/BMI levels in obese hypertensives were higher than obese normotensives (p<0.05). Obese hypertensive women had higher leptin and leptin/BMI levels than obese normotensive women (p<0.05). In conclusion, these results support the hypothesis that a possible link exists between leptin and hypertension. Further studies are needed to clarify how increased levels of leptin affects the pathophysiology of hypertension.
dc.identifier.doi10.1081/ERC-120029889
dc.identifier.endpage105
dc.identifier.issn0743-5800
dc.identifier.issn1532-4206
dc.identifier.issue1
dc.identifier.orcid0000-0002-9206-3177
dc.identifier.orcid0000-0003-3552-7315
dc.identifier.orcid0000-0003-0787-0757
dc.identifier.pmid15098923
dc.identifier.scopus2-s2.0-1842429208
dc.identifier.scopusqualityQ3
dc.identifier.startpage95
dc.identifier.urihttps://doi.org/10.1081/ERC-120029889
dc.identifier.urihttps://hdl.handle.net/11508/48098
dc.identifier.volume30
dc.identifier.wosWOS:000220834000009
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Inc
dc.relation.ispartofEndocrine Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectplasma leptin
dc.subjectessential hypertension
dc.subjectgender
dc.titleComparative analysis of plasma leptin levels in both genders of patients with essential hypertension and healthy subjects
dc.typeArticle

Dosyalar